Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of first-in-class TREM-1 inhibitors for neovascular retinal diseases
Developing a Couples Coping Intervention for Veterans with Heart Failure
Improving Hypertension Control in East/Central Harlem
Research in Perinatal Medicine
Cfda 13.964 - Public Health Traineeships
Recently added grants:
Folding and chaperone interactions of multi-domain proteins
RNA Toxicity and Muscle Regeneration
Epigenetic regulation by tumor suppressor p53
Learning and brain plasticity in children with autism: relation to cognitive inflexibility and restricted-repetitive behaviors
Attentional, temperamental, and physiological process underlying anxiety in preschoolers with ASD
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42200-13-0-1
Application #
7624423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
/ Battelle Centers/Pub Health Research & Evaluatn
$1,230,594
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs
Johnson, Jerry /
$1,001,062
NIH 2007
N01 CA
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
/
Comments
Be the first to comment on this grant